Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development and applications of a BRAF oligonucleotide microarray.

Il-Jin Kim1, Hio Chung Kang, Sang Geun Jang

  • 1Laboratory of Cell Biology, Cancer Research Institute and Cancer Research Center, Seoul National University, Seoul, Korea 110-799.

The Journal of Molecular Diagnostics : JMD
|January 26, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between Ratio of Cholesterols and Coronary Artery Stenosis According to Low-Density Lipoprotein-Cholesterol Levels and Statin Use.

Korean circulation journal·2026
Same author

Differences in coronary angiographic findings and outcomes between men and postmenopausal women with stable chest pain.

Coronary artery disease·2024
Same author

Temporal Changes in Demography and Genetic Diversity of Oriental Storks at the Stage of Long-Term Captive Propagation and Reintroduction Initiation.

Zoological science·2023
Same author

Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells.

Nature communications·2021
Same author

Clinical Cohort Analysis of Germline <i>EGFR</i> T790M Demonstrates Penetrance Across Ethnicities and Races, Sexes, and Ages.

JCO precision oncology·2021
Same author

Incremental value of QT interval for the prediction of obstructive coronary artery disease in patients with chest pain.

Scientific reports·2021
Same journal

Epigenetic CD4+ T-Cell Quantification from Dried Blood Spots Using a qPCR-Based Assay.

The Journal of molecular diagnostics : JMD·2026
Same journal

Segmental Copy Number Variant Detection Using an Amplicon-based NGS Panel for Integrated Glioma Classification.

The Journal of molecular diagnostics : JMD·2026
Same journal

Clinical Validation of the Roche cobas and cobas 4800 Human Papillomavirus Tests on Self-Collected Vaginal Dry Swabs versus Practitioner-Collected Cervical Specimens Using the VALHUDES Protocol.

The Journal of molecular diagnostics : JMD·2026
Same journal

Long-Read Nanopore Sequencing Enhances BRCA1/2 Variant Detection Compared with Ion Torrent Analysis.

The Journal of molecular diagnostics : JMD·2026
Same journal

Endonuclease-Assisted Selective Exponential Amplification for Ultrasensitive Enrichment and Detection of Low-Abundance Mutant Alleles in Lung Cancer.

The Journal of molecular diagnostics : JMD·2026
Same journal

Validation of NTRK Fusion Detection Using an Ultrarapid, Fully Automated Cartridge-Based PCR Assay.

The Journal of molecular diagnostics : JMD·2026
See all related articles

A new competitive DNA hybridization (CDH) method enables sensitive detection of BRAF mutations. This technique offers a faster, more cost-effective approach for identifying cancer-related genetic alterations.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • BRAF somatic mutations are prevalent in various human cancers.
  • Accurate and rapid detection of BRAF mutations is crucial for targeted cancer therapy.
  • Existing mutation detection methods may lack sensitivity or efficiency.

Purpose of the Study:

  • To develop and validate a sensitive microarray hybridization method, competitive DNA hybridization (CDH), for BRAF somatic mutation analysis.
  • To establish a reliable and efficient platform for identifying BRAF mutations in cancer samples.
  • To assess the potential of CDH for facilitating directed therapy in BRAF-mutated tumors.

Main Methods:

  • Development of a competitive DNA hybridization (CDH) assay utilizing fluorescently labeled samples competing for binding to wild-type sequences.

Related Experiment Videos

  • Design and implementation of a BRAF oligonucleotide microarray encompassing 65 known mutation types.
  • Validation of the CDH microarray using 20 colorectal cancer tissues/cell lines with BRAF mutations and 60 BRAF-negative samples.

    • Main Results:

    • The CDH method demonstrated sensitive detection of BRAF somatic mutations.
    • The BRAF microarray successfully identified a high percentage (>95%) of known BRAF mutations.
    • The assay allowed for screening of up to nine cancer samples per microarray, significantly reducing experimental time and cost.

    Conclusions:

    • Competitive DNA hybridization (CDH) is a sensitive and reliable method for detecting BRAF somatic mutations.
    • The developed BRAF microarray platform offers a cost-effective and time-efficient solution for mutation screening.
    • This approach holds promise for advancing personalized medicine by enabling faster diagnosis and directed therapy for BRAF-mutated cancers.